docetaxel anhydrous has been researched along with Adrenocortical Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daugaard, G; Pappot, H; Pawlak, WZ; Petersen, PM; Rørth, M; Urup, T | 1 |
| Hirai, I; Inagaki, T; Kodama, Y; Kokawa, Y; Nishida, M; Okamura, Y; Oura, S; Sakurai, T; Sasaki, R; Shinke, T; Tanino, H; Yoshimasu, T | 1 |
1 trial(s) available for docetaxel anhydrous and Adrenocortical Carcinoma
| Article | Year |
|---|---|
Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Female; Humans; Male; Middle Aged; Survival Analysis; Taxoids; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for docetaxel anhydrous and Adrenocortical Carcinoma
| Article | Year |
|---|---|
[Histoculture drug response assay guided concurrent chemoradiotherapy for lung metastasis from adrenocortical carcinoma--a case report].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mitotane; Taxoids | 2004 |